Professional headshot of Geoffrey Sonn, MD, urologic oncologist at Stanford, Photo Credit: Geoffrey A. Sonn, MD/X
One of the most important distinctions Sonn emphasized is that metastatic prostate cancer, while not considered curable, is often controllable for extended periods of time. In interviews with outlets including Politico and The Los Angeles Times, Sonn pointed to major advances over the past decade that have transformed patient outcomes. New generations of hormone-based medications, he explained, can significantly slow the disease’s progression and allow patients to live productive lives for years.
Sonn contrasted prostate cancer with far more aggressive malignancies, noting that prostate cancer behaves very differently than cancers like pancreatic cancer, which often carry a grim prognosis measured in months. According to Sonn, prostate cancer patients can remain stable for long stretches with proper treatment, particularly when modern therapies are combined. Continue reading…
